Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT06872346
- Status
- Recruiting
Conditions
- Cervical Cancer Screening
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Visit-based IT reminders to patients and practitioners — OTHERTo identify patients due for CCSM, simplify test ordering/referral, and track follow-up, PREDICT will include: 1) automated updating of a patient's problem list with the current cervical screening finding, 2) automated updating of cervical cancer health maintenance topics to the appropriate time interval and follow-up test/ procedure through the use of modifiers, 3) "SmartSets" to standardize ordering of procedures/ specialty referrals.
- Population outreach — OTHERPatients will be sent a reminder letter 90 days prior to the due date via the patient portal or mailed if no portal account (Outreach 1). If needed, four weeks later a phone call from the outreach coordinator reminds patients of the follow-up date if scheduled or helps establish follow-up (Outreach 2). The coordinator could also place an order for a referral and send a reminder to the practitioner to sign it if appropriate. The coordinator will review and document any "alternative care plans" discussed by the PCP and patient.
Study Details
The goal of this PREDICT is to assess a personalize approach to screening and management of cervical cancer testing. The investigators will evaluate patients who are due for a follow up cervical cancer screening in the primary care clinics in the Massachusetts General Brigham system. Patients will be randomized by clinic into three different arms (Arm 1: standard care, Arm 2: visit based reminders, Arm 3: visit based reminders and population health outreach)
Key Dates
- First listed
- Mar 12, 2025
- Start date
- Jul 22, 2026
- Status verified
- Nov 2025
- Primary completion
- Jul 22, 2028
- Completion
- Jan 22, 2029
Study Design
- Enrollment
- 7,500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- No Intervention: Arm 1: Standard CarePatients will receive the usual care provided by their PCP, practice, and/or specialist.
- Active Comparator: Arm 2: Visit Based ReminderVisit based reminders for physicians and patients that will be seen in Epic and Patient Gateway
- Active Comparator: Arm 3: Population Health OutreachVisit based reminders for physicians and patients that will be seen in Epic and Patient Gateway. Patients will received outreach from a population health coordinator. Patients will be sent educational materials, a reminder letter, and if needed, additional help scheduling their follow up appointment.
Primary Outcome Measure
Primary effectiveness outcome [ Time Frame: 120 days ]
Central Contacts
- Jennifer S Hass, MD617-724-1832
- Amy J Wint, MSc
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Brigham | Boston | Massachusetts | 02114 | Lipika Samal |
Find similar trials in Boston, MA
By research site
Related Studies
- Community Gateway to Health StudyEnrolling By Invitation · Harvard School of Public Health (HSPH) · Boston, Massachusetts
- St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in ClinicRecruiting · Milton S. Hershey Medical Center · Reading, Pennsylvania
- Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear CollectionRecruiting · Morehouse School of Medicine · Atlanta, Georgia
- The Use of a Novel Vaginal Speculum for Cervical Cancer Screening in Sunrise Community Health PatientsEnrolling By Invitation · Rocky Vista University, LLC · Englewood, Colorado